Hepatitis C virus subtype distribution and resistance-associated substitutions in high-risk population groups in Guangdong Province, China

被引:1
|
作者
Xie, Shilan [1 ]
Yan, Jin [2 ]
Fu, Xiaobing [1 ]
Yu, Guolong [2 ]
Yan, Xinge [2 ]
Yang, Fang [1 ]
Li, Bosheng [2 ]
机构
[1] Inst HIV AIDS Prevent, Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 511430, Guangdong, Peoples R China
[2] Guangdong Prov Ctr Dis Control & Prevent, Inst Pathogen Microorg, RM 2528,160 Qunxian Rd, Guangzhou 511430, Guangdong, Peoples R China
关键词
Hepatitis C virus; Subtype; NS5A; Resistance-associated substitution; Guangdong; GENOTYPE; 6; ANTIVIRAL DRUGS; HCV INFECTION; PREVALENCE; TRANSMISSION; PATTERNS; NS5A; NS3;
D O I
10.1016/j.meegid.2024.105653
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: In Guangdong Province, hepatitis C virus (HCV) had been found to confer resistance to direct-acting antivirals (DAAs). There were few studies of HCV subtypes and resistance-associated substitutions (RASs) of HCV in different high-risk populations. In this study, we aimed to determine the subtype distribution and the RASs in high-risk population groups, including drug users (DU), men who have sex with men (MSM), female sex workers (FSW), and male patients with sexually transmitted diseases (STD) in Guangdong Province (a highly developed province with a large population). Methods: Using a city-based sampling strategy,1356 samples were obtained from different population groups. Phylogenetic analyses determined subtypes based on Core, NS5B, or NS5A sequences. HCV subtype distribution and RASs in various risk groups and regions were analyzed. Results: Ten subtypes, of which 6 h and 6 k were novel in Guangdong, were identified. The primary subtype among all risk groups was 6a. RASs in 1b and 3a were different from those observed in other studies. Subtype 3b in western Guangdong was higher than the other three regions. No RASs were found in 6a or any other genotype 6. Conclusions: The HCV subtypes are expanding in high-risk populations in Guangdong. Drug use by other risk groups and commercial sex by DU may bridge the dissemination of 6a from DU to other populations. The RAS profiles of 1b and 3a differed from those reported in studies conducted in southwestern China. Further research is required to determine the reason for this discrepancy. Moreover, the combination of RASs was high in subtype 3b. To guide HCV treatment of subtype 3b, pretreatment subtyping of HCV genotype 3 should be considered in western cities in the near future.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Phylogenetic signature and prevalence of natural resistance-associated substitutions for hepatitis C virus genotypes 3a and 3b in southwestern China
    Liu, Xiaoqing
    Chen, Zhiwei
    Tang, Qiao
    Hu, Peng
    JOURNAL OF VIRUS ERADICATION, 2022, 8 (02)
  • [22] High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance-associated substitutions in hepatitis C genotype 3 infection
    von Felden, J.
    Vermehren, J.
    Ingiliz, P.
    Mauss, S.
    Lutz, T.
    Simon, K. G.
    Busch, H. W.
    Baumgarten, A.
    Schewe, K.
    Hueppe, D.
    Boesecke, C.
    Rockstroh, J. K.
    Daeumer, M.
    Luebke, N.
    Timm, J.
    zur Wiesch, J. Schulze
    Sarrazin, C.
    Christensen, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (09) : 1288 - 1295
  • [23] Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant
    Perales, Celia
    Chen, Qian
    Eugenia Soria, Maria
    Gregori, Josep
    Garcia-Cehic, Damir
    Nieto-Aponte, Leonardo
    Castells, Lluis
    Imaz, Arkaitz
    Llorens-Revull, Meritxell
    Domingo, Esteban
    Buti, Maria
    Ignacio Esteban, Juan
    Rodriguez-Frias, Francisco
    Quer, Josep
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 2207 - 2210
  • [24] Evolution and persistence of resistance-associated substitutions of hepatitis C virus after direct-acting antiviral treatment failures
    Jeong, Y.
    Jin, B.
    Lee, H. W.
    Park, H. J.
    Park, J. Y.
    Kim, D. Y.
    Han, K. -H.
    Ahn, S. H.
    Kim, S.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (11) : 1251 - 1259
  • [25] Performance and modification of EGCRISC among hepatitis C virus high-risk groups
    El-Ghitany, E. M.
    Alkassabany, Y. M.
    Farghaly, A. G.
    EPIDEMIOLOGY AND INFECTION, 2020, 148
  • [26] PREVALENCE OF HEPATITIS-C VIRUS (HVC) ANTIBODIES IN HIGH-RISK GROUPS
    RAMONET, M
    VAZQUEZ, L
    GOMEZ, S
    DEREGIBUS, N
    MAKIYA, M
    PALTI, G
    ALVAREZ, E
    RILO, LR
    DIBAR, E
    EPOSTO, M
    REPETTO, H
    NAKWACKI, J
    PEDIATRIC RESEARCH, 1993, 33 (06) : 660 - 660
  • [27] HEPATITIS-C VIRUS-ANTIBODIES IN HIGH-RISK SAUDI GROUPS
    BAHAKIM, H
    BAKIR, TMF
    ARIF, M
    RAMIA, S
    VOX SANGUINIS, 1991, 60 (03) : 162 - 164
  • [28] Reducing the incidence of hepatocellular carcinoma due to hepatitis C virus infection by detecting resistance-associated substitutions in hepatitis C virus NS5A nonstructural protein
    RozainaneeMohd Zain
    Nurul Asshikin Ruslan
    Sairulahkma Awang
    Muhammad Adib Abd Wahab
    Ravindran Thayan
    Cancer Biology & Medicine, 2018, 15(S1) (S1) : 7 - 7
  • [29] Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C
    Ahmed, Hala Rady
    Waly, Nancy G. F. M.
    Abd El-Baky, Rehab Mahmoud
    Yahia, Ramadan
    Hetta, Helal F.
    Elsayed, Amr M.
    Ibrahem, Reham Ali
    PLOS ONE, 2021, 16 (04):
  • [30] Hepatitis TT virus infection in high-risk groups
    Y. Poovorawan
    A. Theamboonlers
    P. Jantaradsamee
    N. Kaew-in
    P. Hirsch
    P. Tangkitvanich
    Infection, 1998, 26 : 355 - 358